Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Identification of a novel fosfomycin-resistant UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) from a soil metagenome.

Cheng G, Hu Y, Lu N, Li J, Wang Z, Chen Q, Zhu B.

Biotechnol Lett. 2013 Feb;35(2):273-8. doi: 10.1007/s10529-012-1074-5. Epub 2012 Nov 10.

PMID:
23143172
2.

Identification of a novel UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) from Vibrio fischeri that confers high fosfomycin resistance in Escherichia coli.

Kumar S, Parvathi A, Hernandez RL, Cadle KM, Varela MF.

Arch Microbiol. 2009 May;191(5):425-9. doi: 10.1007/s00203-009-0468-9. Epub 2009 Mar 11.

5.

Lyme disease enolpyruvyl-UDP-GlcNAc synthase: fosfomycin-resistant MurA from Borrelia burgdorferi, a fosfomycin-sensitive mutant, and the catalytic role of the active site Asp.

Jiang S, Gilpin ME, Attia M, Ting YL, Berti PJ.

Biochemistry. 2011 Mar 29;50(12):2205-12. doi: 10.1021/bi1017842. Epub 2011 Feb 18.

PMID:
21294548
6.

Evidence that the fosfomycin target Cys115 in UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) is essential for product release.

Eschenburg S, Priestman M, Schönbrunn E.

J Biol Chem. 2005 Feb 4;280(5):3757-63. Epub 2004 Nov 5.

7.
8.

A novel inhibitor that suspends the induced fit mechanism of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA).

Eschenburg S, Priestman MA, Abdul-Latif FA, Delachaume C, Fassy F, Schönbrunn E.

J Biol Chem. 2005 Apr 8;280(14):14070-5. Epub 2005 Feb 8.

10.

Structure of MurA (UDP-N-acetylglucosamine enolpyruvyl transferase) from Vibrio fischeri in complex with substrate UDP-N-acetylglucosamine and the drug fosfomycin.

Bensen DC, Rodriguez S, Nix J, Cunningham ML, Tari LW.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012 Apr 1;68(Pt 4):382-5. doi: 10.1107/S1744309112006720. Epub 2012 Mar 27.

12.

Cloning, expression and characterization of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) from Wolbachia endosymbiont of human lymphatic filarial parasite Brugia malayi.

Shahab M, Verma M, Pathak M, Mitra K, Misra-Bhattacharya S.

PLoS One. 2014 Jun 18;9(6):e99884. doi: 10.1371/journal.pone.0099884. eCollection 2014.

13.

Emergence of fosfomycin-resistant isolates of Shiga-like toxin-producing Escherichia coli O26.

Horii T, Kimura T, Sato K, Shibayama K, Ohta M.

Antimicrob Agents Chemother. 1999 Apr;43(4):789-93.

14.

Genomewide overexpression screen for fosfomycin resistance in Escherichia coli: MurA confers clinical resistance at low fitness cost.

Couce A, Briales A, Rodríguez-Rojas A, Costas C, Pascual A, Blázquez J.

Antimicrob Agents Chemother. 2012 May;56(5):2767-9. doi: 10.1128/AAC.06122-11. Epub 2012 Feb 27.

15.

Identification and characterization of new inhibitors of the Escherichia coli MurA enzyme.

Baum EZ, Montenegro DA, Licata L, Turchi I, Webb GC, Foleno BD, Bush K.

Antimicrob Agents Chemother. 2001 Nov;45(11):3182-8.

16.
17.

Two active forms of UDP-N-acetylglucosamine enolpyruvyl transferase in gram-positive bacteria.

Du W, Brown JR, Sylvester DR, Huang J, Chalker AF, So CY, Holmes DJ, Payne DJ, Wallis NG.

J Bacteriol. 2000 Aug;182(15):4146-52.

18.

Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli.

Takahata S, Ida T, Hiraishi T, Sakakibara S, Maebashi K, Terada S, Muratani T, Matsumoto T, Nakahama C, Tomono K.

Int J Antimicrob Agents. 2010 Apr;35(4):333-7. doi: 10.1016/j.ijantimicag.2009.11.011. Epub 2010 Jan 13.

PMID:
20071153
19.

Role of the loop containing residue 115 in the induced-fit mechanism of the bacterial cell wall biosynthetic enzyme MurA.

Schönbrunn E, Eschenburg S, Krekel F, Luger K, Amrhein N.

Biochemistry. 2000 Mar 7;39(9):2164-73.

PMID:
10694381
20.

Thermodynamic characterization of ligand-induced conformational changes in UDP-N-acetylglucosamine enolpyruvyl transferase.

Samland AK, Jelesarov I, Kuhn R, Amrhein N, Macheroux P.

Biochemistry. 2001 Aug 21;40(33):9950-6.

PMID:
11502190
Items per page

Supplemental Content

Write to the Help Desk